The European Commission has ordered another 200 million of the Pfizer / BioNTech coronavirus vaccine, BioNTech announced on Wednesday.
Those doses will come in addition to 300 million previously ordered by the Commission, BioNTech clarified in a press release.
The doses are “expected to be delivered in 2021, with an estimated 75 million to be supplied in the second quarter,” according to BioNTech.
Related News
- Johnson & Johnson coronavirus vaccine submitted for EU approval
- EU vaccines strategy: Lessons to be learned from mistakes
The vaccine by Pfizer and BioNTech was the first to be recommended for approval by the European Medicines Agency (EMA) on 21 December.
Since then, vaccines by Moderna and AstraZeneca / Oxford University have also been approved and Johnson & Johnson has submitted its vaccine for EU approval as well.
EMA could make a decision on that vaccine by the middle of March, the agency has said.
In the meantime, 676.405 coronavirus vaccines by Pfizer / BioNTech, Moderna and AstraZeneca have already been delivered to Belgium as of 14 February.
Jason Spinks
The Brussels Times
